Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, 08 1997, 1682-1685, Vol 41, No. 8
P van Langevelde, JT van Dissel, CJ Meurs, J Renz and PH Groeneveld
Production of exotoxins by staphylococci and streptococci may lead to the
development of toxic shock syndrome (TSS). Because clindamycin inhibits
exotoxin production, its use has been advocated for the treatment of TSS.
However, the bacteriostatic action of clindamycin might be a disadvantage
for the treatment of overwhelming infections. We investigated the effects
of flucloxacillin and gentamicin on exotoxin production, because incubation
with these antibiotics combines bactericidal action with protein synthesis
inhibition. Staphylococcus aureus during the logarithmic and stationary
phases of growth was incubated with either clindamycin, flucloxacillin, or
a combination of flucloxacillin and gentamicin at concentrations of 2 or 10
times the MIC. In logarithmic-phase cultures clindamycin had a static
effect on bacterial growth. After incubation with flucloxacillin, either
alone or in combination with gentamicin, a rapid and large reduction in the
number of viable bacteria was demonstrated. In stationary-phase cultures
none of the antibiotics significantly changed the number of viable
bacteria. TSS toxin 1 (TSST-1) production during logarithmic- phase growth
was inhibited by > or =95% by all antibiotics. In stationary-phase
cultures, clindamycin, flucloxacillin, and the combination of
flucloxacillin and gentamicin inhibited TSST-1 production by 95, 30, and
75%, respectively, compared with the level of exotoxin production in the
controls. The present results indicate that clindamycin inhibits TSST-1
production and exerts bacteriostatic activity in both bacterial growth
phases. Because the combination of flucloxacillin and gentamicin combines
the inhibition of exotoxin production with high bactericidal activity at
least in logarithmic- phase cultures, it should be considered an
alternative to clindamycin for the treatment of exotoxin-mediated diseases,
especially in patients with overwhelming infections.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Combination of flucloxacillin and gentamicin inhibits toxic shock syndrome toxin 1 production by Staphylococcus aureus in both logarithmic and stationary phases of growth
Department of Infectious Diseases, Leiden University Hospital, The Netherlands.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»